Previous close | 0.7660 |
Open | 0.7770 |
Bid | 0.7650 x 160000 |
Ask | 0.8100 x 150000 |
Day's range | 0.7770 - 0.7770 |
52-week range | 0.7000 - 3.6000 |
Volume | |
Avg. volume | 1 |
Market cap | 25.544M |
Beta (5Y monthly) | 0.62 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Cytosorbents' Annual General Meeting to take place on 6th of June CEO Phil Chan's total compensation...
Cytosorbents ( NASDAQ:CTSO ) First Quarter 2024 Results Key Financial Results Revenue: US$9.79m (up 3.6% from 1Q 2023...
Cytosorbents Corporation (NASDAQ:CTSO) Q1 2024 Earnings Call Transcript May 9, 2024 Cytosorbents Corporation beats earnings expectations. Reported EPS is $-0.11717, expectations were $-0.12. Cytosorbents Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to CytoSorbents’ First […]